General Information of DTT (ID: TTL31H0)

DTT Name OX40L receptor (CD134) DTT Info
Gene Name TNFRSF4

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
10 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Rocatinlimab DMG1U5K Atopic dermatitis EA80 Phase 3 [1]
GBR 830 DM2VO9T Atopic dermatitis EA80 Phase 2 [2]
INCAGN01949 DMK7OHI Advanced malignancy 2A00-2F9Z Phase 2 [3]
PF-04518600 DMZMUIL Solid tumour/cancer 2A00-2F9Z Phase 2 [4]
INCAGN1949 DM7OE3X Solid tumour/cancer 2A00-2F9Z Phase 1/2 [5]
Anti-OX40 mab DMFZ52G Prostate cancer 2C82.0 Phase 1 [6]
BGB-A445 DMQMEDH Solid tumour/cancer 2A00-2F9Z Phase 1 [7]
MEDI0562 DMYVBU6 Solid tumour/cancer 2A00-2F9Z Phase 1 [4]
TAK-252 DM1AKNI Solid tumour/cancer 2A00-2F9Z Phase 1 [8]
YH002 DMWVRHD Aggressive cancer 2A00-2F9Z Phase 1 [9]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Clinical Trial Drug(s)
1 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
YH006 DMRECC2 Aggressive cancer 2A00-2F9Z Investigative [10]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis: a multicentre, double-blind, placebo-controlled phase 2b study. Lancet. 2023 Jan 21;401(10372):204-214.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Sequential therapy with INCAGN01949 followed by ipilimumab and nivolumab in two patients with advanced ovarian carcinoma. Gynecol Oncol Rep. 2020 Oct 1;34:100655.
4 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
5 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
6 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1873).
7 Clinical pipeline report, company report or official report of BeiGene.
8 Clinical pipeline report, company report or official report of Shattuck Labs.
9 Clinical pipeline report, company report or official report of Biocytogen
10 Clinical pipeline report, company report or official report of Biocytogen